[CAS NO. 1421373-98-9]  AZ5104

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1421373-98-9]

Store
Catalog
SLK-S7298
Brand
Selleck
CAS
1421373-98-9

DESCRIPTION [1421373-98-9]

Overview

MDLMFCD28899992
Molecular Weight485.58
Molecular FormulaC27H31N7O2
SMILESC=CC(NC1=CC(NC2=NC=CC(C3=CNC4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C)=O

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.0594 mL10.2970 mL20.5939 mL
5 mM0.4119 mL2.0594 mL4.1188 mL
10 mM0.2059 mL1.0297 mL2.0594 mL
50 mM0.0412 mL0.2059 mL0.4119 mL

Description

AZ5104, the demethylated metabolite of AZD-9291, is a potent inhibitor with of <1 nM, 6 nM, 1 nM, and 25 nM for EGFR (L858R/T790M), EGFR (L858R), EGFR (L861Q), and EGFR (wildtype), respectively. Phase 1.

Targets


In vitro

AZ5104 shows great potency against ex19del (2 nM in PC-9), T790M (2 nM in H1975), and wild-type EGFR (33 nM in LOVO) cell lines. AZ5104 causes inhibition of cell viability with IC50 of 3.3 nM, 2.6 nM, 80 nM, and 53 nM for H1975 (T790M/L858R), PC-9 (ex19del), Calu 3 (WT), and NCI-H2073 (WT), respectively.

In vivo

In both C/L858R and C/L+T mice, AZ5104 (5 mg/kg/d, p.o.) induces significant and sustained tumor regression.